Filing Details
- Accession Number:
- 0001209191-14-070588
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-21 14:26:58
- Reporting Period:
- 2014-11-19
- Filing Date:
- 2014-11-21
- Accepted Time:
- 2014-11-21 14:26:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1562229 | F. Patrick Williams | 4698 Willow Road, Suite 100 Pleasanton CA 94588 | Svp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-11-19 | 9,783 | $28.12 | 82,012 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2014-11-20 | 5,000 | $4.62 | 87,012 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-20 | 6,831 | $28.25 | 80,181 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-20 | 4,169 | $28.78 | 76,012 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-11-20 | 5,000 | $0.00 | 5,000 | $4.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 130,000 | 2022-11-18 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the Issuer on November 19, 2014, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU grant on November 19, 2012 of 75,000 shares. The initial grant vested 25% on November 19, 2013 and the remaining vests annually at a rate of 25% per year.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on January 17, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.68 to $28.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.68 to $29.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- 25% of the total number of shares subject to the option vested on November 19, 2013, and the remainder vest in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer.
Billionaire Hedge Funds
